* A Phase 1a trial of TU2670 in endometriosis was selected for
Innovative Start-up Package Program by the Ministry of SMEs and Startups.

**A phase 1b trial of TU2218 was selected as R&D project by 
the Korea Drug Development  Fund (KDDF).  These projects received partial funding from the organizations.